EIT Health Innovation Scandinavian Node Presentation April 13, 2015

EIT Health Innovation Scandinavian Node

To be discussed:

• Aim and type of projects

• Timelines for submission and events

• Brokerage / Match making event in Munich May 8-9

• Focus for the Scandinavian Node

• Kicable projects

• Document review

• Application template

• Discussion how to contact and connect with other partners

Handling the Strategic Challenges

Leverage enabling technologies

Leverage talents

& education

Exploit big data

IMPACT

KPIs Business Objectives

Lifestyle interventions

Self management of health

Overcoming functional loss

Workplace interventions

Treating & managing chronic diseases

Improving healthcare systems

Strategic Challenges

Promote Healthy Living

Support Active Ageing

Improve Healthcare

EIT Health Tools & Enablers

Agei

ng w

ith a

hea

lthy

Brai

n

Thematic Programme(s)

Projects

Projects

Projects

Projects

Projects

Projects

EIT Health Projects

Innovation by Ideas • collaborative projects selected in competitive calls that are “solution-driven” i.e. a potential solution has been identified that either capitalises on an opportunity or addresses a specific problem presented by demographic ageing of the population

Innovation by Design • collaborative projects that are “needs-driven” and start from a recognized market need or societal problems – Non Academic partner collaborations

Head Start • fast-track project opportunities with focus on SMEs and start-ups, funded to rapidly initiate activities

EIT Health Innovation projects

INNOVATION BY IDEAS INNOVATION BY DESIGN HEAD STARTS

MAIN OBJECTIVES

• Bottom-up • Answer to societal challenges & business

objectives

• Top-down • Built on recognized

market needs & societal problem

• Fast activities initiation • SME’s & start-up focus • Pilots, market analysis,

patents scans…

COORDINATOR Core or associate Non academic core EIT Health partners

CLC CONNECTIVITY • Min 2 CLCs • Minimum 2CLCs • 1 or 2 CLC (50/50)

CALL FREQUENCY 1/year 1-2/ year After BP approval Could be any time

EVALUATION PROCESS ~6 months Evaluation Committee

< 6 months Evaluation Committee

1 month Approval at CLC level

# PROJECTS FOR 2016* Up to 14 Up to 7 Up to 25

# PROJECTS FOR 2017* Up to 22 Up to 11 Up to42

INDICATIVE TOTAL BUDGET Open question to exco Open question to exco 50K€ (capped)

* Depending on final budget allocation

6

Major deadlines in Start-up phase

2015 2016

Jun 30 Jul 30 Sep 01 Oct 31 Sep 30 April 1 Jun 22 Mar 24 Dec 31 April 22

Jun 1 – Electronic application filing system in place May 8-9 Brokerage / match making event in Munich

• Requires an open innovation environment – “rules of engagement” / “code of conduct”

• Gives access to sharing: – Ideas – Unmet clinical needs and market understanding – Solutions and early stage product concepts

• Requires a Win/Win set up • Utilize strengths of each partner

– Registries, patient cohorts, applied technical solutions

Innovation in Public / Private partnerships Focus for the Scandinavian node

17 Years

<7 Years

EIT Health Scandinavian partners

Unmet Needs

Københavns Universitet

Novo Nordisk A/S

Thermo Fisher Scientific Phadia AB

Kungliga Tekniska Högskolan (KTH)

LEO Pharma A/S

RISE Research Institutes of Sweden AB

Stockholms Stad

Capital Region of Denmark (incl. Rigs-hospitalet)

Uppsala universitet

Research Definition

Implementation Applications/models Products Society – Health Care – Industry/Business -- Education / Academia

Karolinska Institutet

Uppsala City Council

Stockholms Läns Landsting (incl. Karolinska University Hospital)

Södertörn Councils PKA Pension

Uppsala County Council (incl. Uppsala University Hospital)

University of Tartu SveaNor

Innovation is the creation of a viable new offering/solution1

Innovation requires identifying the problems that matter and moving through them systematically to deliver elegant solutions1

1) From Ten types of Innovation by Larry Keely http://eu.wiley.com/WileyCDA/WileyTitle/productCd-1118504240.html

Tieto Enator

EIT Health Test bed Scandinavia

Unmet Needs

Københavns Universitet

Novo Nordisk A/S

Thermo Fisher Scientific Phadia AB

Kungliga Tekniska Högskolan (KTH)

LEO Pharma A/S

RISE Research Institutes of Sweden AB

Stockholms Stad

Capital Region of Denmark (incl. Rigs-hospitalet)

Uppsala universitet

Research Definition

Implementation Applications/models Products Society – Health Care – Industry/Business -- Education / Academia

Karolinska Institutet

Uppsala City Council

Stockholms Läns Landsting (incl. Karolinska University Hospital)

Södertörn Councils PKA Pension

Uppsala County Council (incl. Uppsala University Hospital)

University of Tartu SveaNor

The Creation of the Scandinavian CLC test bed for problem definition, solution implementation and health economy analysis has been essential for the EIT Health KIC. The test bed includes full access to: - Registries - Biobanks - Health care cost across providers - Societal QoL analysis

Testbed Scandinavia

• Why is this example important for the node? – Strong public partner participation and infrastructure in Scandinavia

– Possibilities of public/private cooperation –KIC provides access both ways! • Purpose:

– Build-up of effective and seamless care based on telemedicine/eHealth and covering various established registries. Empowered citizens. Strong educational aspects, clinical fellowships.

10

Capital Region of Denmark (incl. Rigs-hospitalet)

Uppsala City Council

Stockholms Läns Landsting (incl. Karolinska University Hospital) Södertörn Councils

PKA Pension

Uppsala County Council (incl. Uppsala University Hospital)

Personalized Oncology Project

• Why is this example important for the node? – KPIs: companies formed, products and services launched – Access to registries and start-ups, above and beyond regular activities

• Purpose: – Application of integration of genetics, biomarkers, algorithms and systems on cancer.

Goal is to provide structured unified and individualized view on cancer diagnosis and treatment. 60 000 prostate cancer patients screened, reduction of biopsies ~25%. Strong educational aspects.

11

Mobility and independence throughout life

• Why is this example important for the node? – KPIs: companies formed, products and services launched – Access to start-ups, above and beyond regular activities

• Purpose: Profound need for radical innovations with reduced costs to support independent life for people with disease / disability or high risk of immobility at home and at work. Early interventions are necessary to prolong positive contributions to society, maintaining physical shape, prevention of falls. Bring together key partners from industry, academia and the public to develop innovative assistive technologies and person-centred supportive and feedback systems (such as augmented reality eyewear) that protect against immobility. Develop educational and motivational systems for citizens, relatives, home care providers, and clinicians. Support the development and market uptake of these applications at home and at work through embedded lab testing and co-creation which will be provided by the different partners. The project will make this a reality by giving people with disease /disability or high risk of immobility the opportunity to actively participate in secondary prevention actions and by making those interventions more effective (and cost-effective), integrative, and easy to implement. It is estimated that a moderate increase in exercise in the European population could potentially increase the number of healthy life time by two years.

12

Ageing with a Healthy Brain • Why is this example important for the node?

– KPIs: companies formed, products and services launched – Utilization of already existing excellent databases

• Purpose: – Development of performance indicators, interfaces and pilot application. As support for

the platform, development of predictivity –analysis based on already existing databases. Develop an alert system. Validate and implement a software for appropriate use of drugs & adherence

• Planning & Activities – Developing and implement risk scores for dementia: – Developing and implementing software for a safe and appropriate use of drugs – Developing new biomarkers for AD – Developing new neuroimaging , including new tracers, for AD and other dementias

13

Metabolic Health

• Why is this example important for the node? – KPIs: students accessed and enrolled – Access to start-ups, above and beyond regular activities

• Purpose: – Structured clinical process. Structured preventative process. Focus on real-world results. Strong

educational aspects. Health coaches. Outreach. Early detection. Development of accurate and minimal invasive metabolic sensors, small and accurate drug delivery systems, and algorithms that control drug delivery in a model-predicted manner. Demonstration trials, scale-up facilitation, market diffusion & ecosystem building, products and services for citizens & patients

14

KICable Projects

Must have

• Clear and achievable commercial end-points (products, services etc.) • Partners from at least two CLCs* • Goals that are in-line with EIT Health business objectives • Strong impact of EIT financing on overall project goals • Include elements of Campus (education) • Identifiable in kind financing • Strong added values of the KIC partnership : KIC added value • Clear deployment activities and union added value

Nice to have

• Strong market input, including buyers where relevant (i.e. where buyers and end-users are not the same)

• Can be applicable throughout EU (with minor modifications) • Basis in existing projects of the partners • Mixture of industry / public partners & academia in project team • Inclusion of SMEs*

Must not have

• Partner(s) from only one CLC* • Unachievable commercial end-points within the lifetime of EIT Health • Need to carry out basic research (TRL 1-3)

*with the exception of Headstart projects

Innovation Application Documents NOTE: This is still work in progress

• The Template: Innovation_Project_Proposal_Template_FinalIMT_April12.docx

• The Call for Innovation Proposal: Call_for_Innovation_Proposals_FinalIMT_April12th.docx

• The Eligibility & Evaluation Criteria: Eligibility_and_Evaluation_Criteria_FinalIMT_April12.docx

• The Guidelines: Advice_and_Information_for_Project_Proposal_FinalIMT_April12.docx

• The Guide for TRL: A guide for TRL-EIT Health.pdf

FAQs – Please provide additional questions in order to explain and improve

Project selection criteria • I. Project contributions to EIT health planned outcomes

• Quality of innovation beyond state of the art – Excellence of innovation in relation to Gold standard, best practices

• Internal KPI’s (Management, Financial)

• External KPI´s (Education, Business Innovation, Communication)

• II. Potential for commercialization and scalability

• International competition

• Perspectives on new strategic approaches for international cooperation

• Leveraging and boosting Industry engagement, in particular SME´s

• Clear identification of products and/or services to be launched (TRL of the project at the beginning and at the end of the project, Time to market..)

• Business plan

• Capacity of the partners to bring innovation to the market

• Total value of the project (KIC financing, KAVA financing) & Valorization

• Justification of market segment/ End user/ Market(s) targeted in Europe

• Barriers (IP, regulatory, ethics, market…), SWOT

• Feasibility of the deployment activities and planning

• III. Project impact

• Health economy and sustainability of Healthcare Systems

• Quality of Life

• Economic Growth

• Human Capital & Job Creation

How to connect to partners

• Prepare a short description of your project and provide to your Innovation coordinator

• Describe your interest and partner criteria

• Make sure that your Innovation Coordinator will present this at the Brokerage meeting in Munich. At least one person from each of the ~140 partners will attend.

• Make personal contact with different partners also outside the brokerage event.